Clinical trials
2 active studies led by Urmila DIwekar, of 2 in all
Source: ClinicalTrials.gov, Studies with Urmila DIwekar (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Urmila DIwekar in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Urmila DIwekar or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 active studies led by Urmila DIwekar, of 2 in all
Source: ClinicalTrials.gov, Studies with Urmila DIwekar (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Markets we cover where free public records show Urmila DIwekar: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Urmila DIwekar is in.
Stories on the topics Urmila DIwekar works in.
Anaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth…
Read
Breast cancer is the most common cancer in women worldwide. Finding it early saves lives, but access to…
Read
About 1 in 6 adults experience infertility. In many countries one IVF cycle costs more than a year's income.
Read